The vaccine has been registered in India under the emergency use authorisation procedure based on results of clinical trials in Russia, interim analysis of which an efficacy of 91.6%
from mint - Science https://ift.tt/3wKwkM1
https://ift.tt/eA8V8J
from mint - Science https://ift.tt/3wKwkM1
https://ift.tt/eA8V8J
إرسال تعليق